Day: March 16, 2022

MariMed Doubles Full Year Revenue and Adjusted EBITDA As It Reports Fourth Quarter and Full Year 2021 Earnings

Written by Customer Service on March 16, 2022. Posted in Earnings Releases And Operating Results.

MariMed Exceeds Guidance with Full Year Revenue of $121.5 Million and Adjusted EBITDA of $43.1 Million NORWOOD, Mass., March 16, 2022 (GLOBE NEWSWIRE) — MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial and operating results for the fourth quarter and full year ended December 31, 2021. FOURTH QUARTER AND FULL YEAR FINANCIAL HIGHLIGHTSFourth quarter revenue of $31.0 million and full year revenue of $121.5 million, an increase of 52% and 139%, respectively, compared to the same periods from the prior year. Fourth quarter gross profit of $15.5 million and full year gross profit of $66.3 million, an increase of 33% and 112%, respectively, compared to the same periods from the prior year. Fourth quarter Adjusted EBITDA*...

National Fuel Announces Management Changes

Written by Customer Service on March 16, 2022. Posted in Public Companies.

Michael Kasprzak President of National Fuel Gas Midstream Company, LLC (Midstream), will retire on April 1Justin I. Loweth President of Seneca Resources Company, LLC (Seneca Resources), has been appointed as President of MidstreamJames Welch Promoted to Vice President of MidstreamJeffrey F. Hart Vice President of Corporate Responsibility, will retire effective June 1, 2022Sarah J. Mugel National Fuel’s General Counsel and Corporate Secretary, has been appointed as the officer with oversight for the Company’s Corporate Responsibility functionMeghan A. Corcoran Has been named General Manager of Corporate ResponsibilityWILLIAMSVILLE, N.Y., March 16, 2022 (GLOBE NEWSWIRE) — Today, National Fuel Gas Company (National Fuel or the Company) (NYSE: NFG) announced that Michael Kasprzak, President of National Fuel Gas Midstream...

Progenity to Report Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update

Written by Customer Service on March 16, 2022. Posted in Public Companies.

SAN DIEGO, March 16, 2022 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2021 on Monday, March 28, 2022 after the close of financial markets. Progenity’s management will host a webcast and conference call at 4:30 p.m. Eastern / 1:30 p.m. Pacific that day to discuss the financial results and provide a corporate update. The live call may be accessed by dialing 877-423-9813 for domestic callers or 201-689-8573 for international callers and entering the conference code: 13727360. A live webcast will be available online in the Investor Relations section of the company website at www.progenity.com and a replay will...

Capital Bank Announces New EVP/CIO to Further Advance its Strategic Digital Goals

Written by Customer Service on March 16, 2022. Posted in Public Companies.

ROCKVILLE, Md., March 16, 2022 (GLOBE NEWSWIRE) — Capital Bank, N.A., is pleased to announce the appointment of Sandeep Uthra as the Bank’s Executive Vice President, Chief Information Officer (CIO). The addition of Uthra to the executive team helps further advance Capital Bank’s commitment to technology-driven banking solutions for business owners and consumers. “As we transform even further to digital as an organization,” says Ed Barry, Chief Executive Officer (CEO), “we must centralize this function. With the appointment of Uthra, we can get more leverage from our investment in information and technology, helping us to offer more transformative solutions to our broader customer set.” Uthra brings decades of experience and expertise to Capital Bank. He joined Capital Bank recently as EVP/CIO reporting directly to Ed Barry. In...

Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

Written by Customer Service on March 16, 2022. Posted in Earnings Releases And Operating Results.

Total 2021 Revenues Increased Approximately 18% YoY to $141 Million Strong 2022 Revenue Growth Expected, Supported by FIRDAPSE® Orphan Drug Exclusivity New Patent Issuances Strengthens FIRDAPSE Long-Term Commercial Potential to 2034 Actively Pursuing Opportunities to Diversify Commercial and Development Portfolio Strong Cash and Investments Position of $191 Million and No Funded Debt Company to Host a Conference Call and Webcast on March 17, 2022, at 8:30 AM ET CORAL GABLES, Fla., March 16, 2022 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today reported financial results for the fourth quarter and full year 2021 and provided...

LXP Industrial Trust Announces Quarterly Common Share Dividend

Written by Customer Service on March 16, 2022. Posted in Dividend Reports And Estimates.

NEW YORK, March 16, 2022 (GLOBE NEWSWIRE) — LXP Industrial Trust (“LXP”) (NYSE: LXP), a real estate investment trust (REIT) focused on single-tenant industrial real estate investments, today announced that it declared a regular common share/unit dividend/distribution for the quarter ending March 31, 2022 of $0.12 per common share/unit payable on or about April 18, 2022 to common shareholders/unitholders of record as of March 31, 2022. LXP also declared a cash dividend of $0.8125 per share of Series C Cumulative Convertible Preferred Stock for the quarter ending March 31, 2022, which is payable on or about May 16, 2022, to shareholders of record as of April 29, 2022. ABOUT LXP INDUSTRIAL TRUST LXP Industrial Trust (NYSE: LXP) is a publicly traded real estate investment trust (REIT) focused on single-tenant warehouse and distribution...

Athenex Provides Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

Written by Customer Service on March 16, 2022. Posted in Earnings Releases And Operating Results.

Announces Strategic Pivot to Focus on Cell Therapy Programs Receives FDA Clearance for IND to Expand CD19 CAR-NKT ANCHOR to a Multi-center Study Implementing Significant Cost Reduction Plan Targeting >50% Reduction in Operating Expenses Plans to Extend Cash Runway in 2022 Through Monetization of Non-core Assets Consistent with Shift in Focus and Strategy Management to host conference call and webcast today at 4:30 p.m. ET BUFFALO, N.Y., March 16, 2022 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today provided a corporate and financial update for the fourth quarter and full year ended December 31, 2021. “We are pleased to announce our new vision for the future...

Montauk Renewables Announces Full Year 2021 Results

Written by Customer Service on March 16, 2022. Posted in Earnings Releases And Operating Results.

PITTSBURGH, March 16, 2022 (GLOBE NEWSWIRE) — Montauk Renewables, Inc. (“Montauk” or “the Company”) (NASDAQ: MNTK), a renewable energy company specializing in the management, recovery and conversion of biogas into renewable natural gas (“RNG”), today announced financial results for the year ended December 31, 2021. Full Year Highlights:Revenues of $148.1 million, increased 47.5% year-over-year Net Loss of $4.5 million, decreased 198.4% year-over-year Non-GAAP Adjusted EBITDA of $28.0 million, increased 7.2% year-over-year RNG production of 5.7 million MMBtu, unchanged from prior yearMontauk’s full year revenue reflects an approximate 45.5% increase in realized D3 RIN pricing and an approximate 46.0% increase in natural gas prices in 2021 over 2020. To a lesser extent, higher revenues recognized under counterparty sharing agreements...

Brilliant Earth Reports Outstanding Fourth Quarter and Fiscal Year 2021 Results

Written by Customer Service on March 16, 2022. Posted in Earnings Releases And Operating Results.

Delivered 51.0% Net Sales Growth for Fiscal Year 2021 Generated Net Income of $26.3 million and Adjusted EBITDA of $50.5 million for Fiscal Year 2021 Generated Q4 GAAP Diluted EPS of $0.09 and Adjusted Diluted EPS of $0.11 Introduces Fiscal 2022 Outlook SAN FRANCISCO, March 16, 2022 (GLOBE NEWSWIRE) — Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (Nasdaq: BRLT), an innovative, digital-first jewelry company and global leader in ethically sourced fine jewelry, today announced financial results for the three and twelve months ended December 31, 2021. Fourth Quarter and Fiscal Year 2021 Highlights (quarterly and annual periods ended December 31, 2021):Net sales were $121.9 million and $380.2 million for the fourth quarter and fiscal year, respectively. Net sales increased by 37.6% and 51.0% for the fourth quarter...

Hallmark Announces Fourth Quarter and Fiscal 2021 Results

Written by Customer Service on March 16, 2022. Posted in Earnings Releases And Operating Results.

Hallmark Financial Services, Inc. Hallmark Financial Services, Inc.DALLAS, March 16, 2022 (GLOBE NEWSWIRE) — Hallmark Financial Services, Inc. (“Hallmark”) (NASDAQ: HALL) today announced financial results for the fourth quarter and fiscal year ended December 31, 2021. Highlights:Pre-tax loss was ($3.1) million for the three months ended December 31, 2021, as compared to pre-tax loss of ($13.3) million reported during the same period in 2020. Pre-tax income was $11.5 million for the fiscal year ended December 31, 2021, as compared to a pre-tax loss of ($115.8) million for fiscal 2020.Net loss was ($2.5) million, or ($0.14) per diluted share, in the fourth quarter of 2021 as compared to net loss of ($7.8) million, or ($0.43) per diluted share, for the same period of 2020. Fiscal 2021 net income was $9.0 million, or $0.50 per...

Day: March 16, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice